Pol S - Search Results

1

Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial.

Colombo M, Aghemo A, Liu H, Zhang J, Dvory-Sobol H, Hyland R, Yun C, Massetto B, Brainard DM, McHutchison JG, Bourlière M, Peck-Radosavljevic M, Manns M, Pol S. Colombo M, et al. Among authors: pol s. Ann Intern Med. 2017 Jan 17;166(2):109-117. doi: 10.7326/M16-1205. Epub 2016 Nov 15. Ann Intern Med. 2017. PMID: 27842383 Clinical Trial.

2

Absence of hepatitis delta virus infection in chronic hemodialysis and kidney transplant patients in france.

Pol S, Dubois F, Mattlinger B, Carnot F, Legendre C, Bréchot C, Berthelot P, Kreis H. Pol S, et al. Transplantation. 1992 Dec;54(6):1096-7. doi: 10.1097/00007890-199212000-00027. Transplantation. 1992. PMID: 1465775

3

Is hepatitis C virus involved in hepatitis-associated aplastic anemia?

Pol S, Driss F, Devergie A, Brechot C, Berthelot P, Gluckman E. Pol S, et al. Ann Intern Med. 1990 Sep 15;113(6):435-7. doi: 10.7326/0003-4819-113-6-435. Ann Intern Med. 1990. PMID: 2117412

4

Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.

Pol S, Saltiel C, Legendre C, Carnot F, Driss F, Berthelot P, Bréchot C, Ruet C, Kreis H. Pol S, et al. Nephrol Dial Transplant. 1994;9(7):820-3. Nephrol Dial Transplant. 1994. PMID: 7526277 Clinical Trial.

5

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.

Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Bréchot C. Nousbaum JB, et al. Among authors: pol s. Ann Intern Med. 1995 Feb 1;122(3):161-8. doi: 10.7326/0003-4819-122-3-199502010-00001. Ann Intern Med. 1995. PMID: 7810932

6

The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients.

Pol S, Thiers V, Nousbaum JB, Legendre C, Berthelot P, Kreis H, Brechot C. Pol S, et al. Gastroenterology. 1995 Feb;108(2):581-3. doi: 10.1016/0016-5085(95)90088-8. Gastroenterology. 1995. PMID: 7835601

7

Eradication of hepatitis C virus RNA after alpha-interferon therapy.

Romeo R, Pol S, Berthelot P, Brechot C. Romeo R, et al. Among authors: pol s. Ann Intern Med. 1994 Aug 15;121(4):276-7. doi: 10.7326/0003-4819-121-4-199408150-00008. Ann Intern Med. 1994. PMID: 8037409 No abstract available.

8

Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis.

Pol S, Cavalcanti R, Carnot F, Legendre C, Driss F, Chaix ML, Thervet E, Chkoff N, Brechot C, Berthelot P, Kreis H. Pol S, et al. Transplantation. 1996 Jun 27;61(12):1774-6. doi: 10.1097/00007890-199606270-00019. Transplantation. 1996. PMID: 8685959

9

Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients.

Legendre C, Garrigue V, Le Bihan C, Mamzer-Bruneel MF, Chaix ML, Landais P, Kreis H, Pol S. Legendre C, et al. Among authors: pol s. Transplantation. 1998 Mar 15;65(5):667-70. doi: 10.1097/00007890-199803150-00011. Transplantation. 1998. PMID: 9521201

10

Treatment of chronic hepatitis C.

Pol S, Bréchot C. Pol S, et al. Acta Gastroenterol Belg. 1999 Jan-Mar;62(1):32-9; discussion 39-40. Acta Gastroenterol Belg. 1999. PMID: 10333597 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

919 results

Search Page